Ian C. A. Taylor

发表论文 84 篇 · 总被引 7899 次 · h-index 22

代表论文

BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (2004 · Cancer Research · 被引 4058)
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (2006 · Journal of Clinical Oncology · 被引 1205)
Sorafenib (BAY 43‐9006, Nexavar®), a Dual‐Action Inhibitor That Targets RAF/MEK/ERK Pathway in Tumor Cells and Tyrosine Kinases VEGFR/PDGFR in Tumor Vasculature (2006 · Methods in enzymology on CD-ROM/Methods in enzymology · 被引 475)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models (2006 · Cancer Chemotherapy and Pharmacology · 被引 467)
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models (2024 · Clinical Cancer Research · 被引 193)
Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader (2024 · Molecular Cancer Therapeutics · 被引 88)